| 2025 |
Wright, L., Wignall, A., Subramaniam, S., Schultz, H. B., Joyce, P., & Prestidge, C. A. (2025). Enhanced oral absorption and biodistribution to submandibular salivary glands of D-limonene in Sprague Dawley rats via a liquid-lipid formulation approach. International Journal of Pharmaceutics, 670(125179), 125179.
DOI Scopus1 WoS1 Europe PMC1 |
| 2025 |
Subramaniam, S., Donnellan, L., Wignall, A., Woodcock, J., Coolen, C., Pitson, S., . . . Joyce, P. (2025). Polymeric-lipid nanoparticles that leverage cationic helper lipids and the protein corona for lung-targeted delivery of a novel anti-cancer drug. Journal of Controlled Release, 388(Pt 1), 15 pages.
DOI |
| 2025 |
Mahboob, M. B. H., Subramaniam, S., Tait, J. R., Grace, J. L., Elliott, A. G., Floyd, H., . . . Whittaker, M. R. (2025). Cholesterol-terminated cationic lipidated oligomers (CLOs) as a new class of antifungals. Journal of Materials Chemistry B, 13(8), 2776-2795.
DOI |
| 2025 |
Ahsan, A., Barnes, T. J., Thomas, N., Subramaniam, S., & Prestidge, C. A. (2025). Lipid-based nanocarriers for enhanced gentamicin delivery: a comparative study of liquid crystal nanoparticles and liposomes against Escherichia coli biofilms. Drug Delivery And Translational Research, online(11), 1-22.
DOI Scopus1 WoS1 |
| 2024 |
Subramaniam, S., Joyce, P., & Prestidge, C. A. (2024). The biomolecule corona mediates pulmonary delivery of nanomedicine. European Journal of Pharmaceutics and Biopharmaceutics, 202(114420), 1-8.
DOI Scopus4 WoS5 Europe PMC1 |
| 2024 |
Ahsan, A., Thomas, N., Barnes, T. J., Subramaniam, S., Loh, T. C., Joyce, P., & Prestidge, C. A. (2024). Lipid nanocarriers-enabled delivery of antibiotics and antimicrobial adjuvants to overcome bacterial biofilms. Pharmaceutics, 16(3, article no. 396), 1-46.
DOI Scopus41 WoS38 Europe PMC25 |
| 2024 |
Subramaniam, S., Joyce, P., Conn, C. E., & Prestidge, C. A. (2024). Cellular uptake and in vitro antibacterial activity of lipid-based nanoantibiotics are influenced by protein corona. Biomaterials Science, 12(13), 3411-3422.
DOI Scopus8 WoS8 Europe PMC6 |
| 2024 |
Iscaro, J., Yu, H., Martinez, N., Subramaniam, S., Joyce, P., Wang, H., . . . Zhai, J. (2024). Lyotropic liquid crystalline phase nanostructure and cholesterol enhance lipid nanoparticle mediated mRNA transfection in macrophages. Advanced Functional Materials, 34(no. 46, article no. 2405286), 1-15.
DOI Scopus12 WoS13 |
| 2024 |
Subramaniam, S., Joyce, P., Ogunniyi, A. D., Dube, A., Sampson, S. L., Lehr, C. M., & Prestidge, C. A. (2024). Minimum Information for Conducting and Reporting In Vitro Intracellular Infection Assays. ACS Infectious Diseases, 10(2), 337-349.
DOI Scopus6 WoS6 Europe PMC6 |
| 2024 |
Joyce, P., Allen, C. J., Alonso, M. J., Ashford, M., Bradbury, M. S., Germain, M., . . . Santos, H. A. (2024). A translational framework to DELIVER nanomedicines to the clinic. Nature Nanotechnology, 19(11), 1597-1611.
DOI Scopus124 WoS113 Europe PMC92 |
| 2023 |
Subramaniam, S., Elz, A., Wignall, A., Kamath, S., Ariaee, A., Hunter, A., . . . Joyce, P. (2023). Self-emulsifying drug delivery systems (SEDDS) disrupt the gut microbiota and trigger an intestinal inflammatory response in rats. International Journal of Pharmaceutics, 648(123614), 123614-1-123614-10.
DOI Scopus32 WoS28 Europe PMC19 |
| 2023 |
Subramaniam, S., Joyce, P., Donnellan, L., Young, C., Wignall, A., Hoffmann, P., & Prestidge, C. A. (2023). Protein adsorption determines pulmonary cell uptake of lipid-based nanoparticles. Journal of Colloid and Interface Science, 641, 36-47.
DOI Scopus32 WoS31 Europe PMC23 |
| 2023 |
Subramaniam, S., Joyce, P., & Prestidge, C. A. (2023). Liquid crystalline lipid nanoparticles improve the antibacterial activity of tobramycin and vancomycin against intracellular Pseudomonas aeruginosa and Staphylococcus aureus. International Journal of Pharmaceutics, 639(639, article no. 122927), 1-9.
DOI Scopus14 WoS13 Europe PMC10 |
| 2023 |
Subramaniam, S., Kamath, S., Ariaee, A., Prestidge, C., & Joyce, P. (2023). The impact of common pharmaceutical excipients on the gut microbiota. Expert Opinion on Drug Delivery, 20(10), 1297-1394.
DOI Scopus26 WoS26 Europe PMC19 |
| 2021 |
Subramaniam, S., Joyce, P., Thomas, N., & Prestidge, C. A. (2021). Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections. Advanced Drug Delivery Reviews, 177(113948), 1-23.
DOI Scopus81 WoS79 Europe PMC60 |
| 2020 |
Joyce, P., Ulmefors, H., Maghrebi, S., Subramaniam, S., Wignall, A., Jõemetsa, S., . . . Prestige, C. A. (2020). Enhancing the cellular uptake and antibacterial activity of rifampicin through encapsulation in mesoporous silica nanoparticles. Nanomaterials, 10(4), 1-16.
DOI Scopus35 WoS32 Europe PMC25 |
| 2019 |
Subramaniam, S., Thomas, N., Gustafsson, H., Jambhrunkar, M., Kidd, S. P., & Prestidge, C. A. (2019). Rifampicin-Loaded Mesoporous Silica Nanoparticles for the Treatment of Intracellular Infections.. Antibiotics (Basel, Switzerland), 8(2), 15 pages.
DOI Scopus57 WoS46 Europe PMC40 |
